1.900
+5,56%
2026-10-16
Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -818.8% | -191.4% | 1 / 3 | -3.2% | -5.23 pp | -7.27 pp | +6.8% | -1.69 | — | 115 | −3,2% | −7,3 | −818,8% | — | -14.00 | — |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.900 (close price on 2026-10-16)EPS (TTM): −466,4
Financial charts
1.Revenue & growth
VND bn115Q2/26
1.Revenue & growth
VND bn115Q2/26
2.Profit & growth
VND bn-7,14Q2/26
3.Profit mix (Penman)
VND bn-12,9Q2/26
4.Margins & cost structure
%7.3%Q2/26
5.Returns & cash cycle
% · days10.8%Q2/26
6.Earnings quality & cash
VND bn42,2Q2/26
7.Asset structure
VND bn249Q2/26
8.Funding & debt health
VND bn · times249Q2/26
9.Revenue backlog
VND bn7,00Q2/26
10.Valuation
times · %-3,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-254Q2/26
Adjusted EPS growth, latest quarter
-799%
Average adjusted EPS growth, 3 quarters
-265%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26